Amyloidotic cardiomyopathy: multidisciplinary approach to diagnosis and treatment.
Heart Fail Clin
; 7(3): 385-93, 2011 Jul.
Article
em En
| MEDLINE
| ID: mdl-21749890
ABSTRACT
Amyloidotic cardiomyopathy (ACMP) occurs in the setting of rare genetic diseases, blood dyscrasias, chronic infection and inflammation, and advanced age. Cardiologists are on the front lines of diagnosis of ACMP when evaluating patients with unexplained dyspnea, congestive heart failure, or arrhythmias. Noninvasive detection of diastolic cardiac dysfunction and unexplained left ventricular hypertrophy should be followed by biopsy to demonstrate the presence of amyloid deposits and appropriate genetic, biochemical, and immunologic testing to accurately define the type of amyloid. Growing numbers of treatment options exist for these diseases, and timely diagnosis and institution of therapy is essential for preservation of cardiac function.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Função Ventricular Esquerda
/
Amiloide
/
Amiloidose
/
Cardiomiopatias
/
Miocárdio
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
Limite:
Humans
Idioma:
En
Revista:
Heart Fail Clin
Ano de publicação:
2011
Tipo de documento:
Article
País de afiliação:
Estados Unidos